Masimo Corporation (NASDAQ:MASI) will be discussing 3Q20 financial results with the investment community.on 27th October 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.masimo.com
Earnings Expectation
Masimo Corporation is set to announce third quarter earning results on Tuesday 27th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, MASI to report 3Q20 income of $ 0.62 per share. For the full year, analysts anticipate top line of $ 1091.30 million, while looking forward to income of $ 3.17 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 274.00 million ~ $ 278.00 million
Full Year 2020 topline are forecasted in a range of$ 1,124.00 million ~ $ 1,128.00 million, where as bottomline are predicted in a range of $ 3.56 ~ $ 3.56 per share
Click Here For More Historical Outlooks Of Masimo Corporation
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.
